Owners, management and financials
CVR: 33777604
Previous names: NEUROLOGISK KLINIK SØNDERBORG ApS, NEUROLOGISK SPECIALLÆGEKLINIK AALBORG ApS
DKK 2,685,509
Gross profit
Net result: DKK 964,553
SAMBO HOLDING ApS (100%)
CVR · view owners
Martin Tøttrup Kelkelund
CVR · view management
Active
Founded 21 June 2011
CVR · view overview
3 employees
CVR · 2026
Name registered: NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS
CVR · 30/08/2019
View the full event history
NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS is a Danish company of the type Anpartsselskab based in Sæby, founded in 2011. The company is registered under the industry Speciallægers aktiviteter. The company was previously named NEUROLOGISK SPECIALLÆGEKLINIK AALBORG ApS and NEUROLOGISK KLINIK SØNDERBORG ApS. The management consists of Martin Tøttrup Kelkelund. The company is owned by SAMBO HOLDING ApS. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 2,685,509 and a net result of DKK 964,553 compared with DKK 794,444 the year before. Equity in the 2025 report amounted to DKK 3,478,048.
Source: annual report 2025, Danish Business Authority
The financial health of NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS appears stable, with consistent gross profit and profit figures over the past few years. Gross profit has shown a slight increase from 2,100,905 DKK in 2022 to 3,079,789 DKK in 2023, while profit rose from 748,323 DKK to 1,191,585 DKK in the same period. However, equity has fluctuated, decreasing from 6,513,495 DKK in 2024 to 3,478,048 DKK in 2025, which could indicate potential concerns regarding financial stability. The company operates within the specialized medical sector, suggesting a niche position, but the lack of disclosed revenue limits a comprehensive assessment of its market size and competitive standing.
AI-generated summary · Generated 15/08/2026
Selskabets formål er at drive speciallægepraksis i Danmark
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 2.7M | 965K | 4.9M | 3.5M | 3 | |
| 202401/01/2024 – 31/12/2024 | 2.5M | 794K | 7.8M | 6.5M | 3 | |
| 202301/01/2023 – 31/12/2023 | 3.1M | 1.2M | 7.1M | 5.7M | 3 | |
| 202201/01/2022 – 31/12/2022 | 2.1M | 748K | 5.4M | 4.5M | 2 | |
| 202101/01/2021 – 31/12/2021 | 2.7M | 1.2M | 4.9M | 3.8M | 2 | |
| 202001/01/2020 – 31/12/2020 | 2.6M | 1.2M | 3.8M | 2.6M | 2 | |
| 201901/01/2019 – 31/12/2019 | 2M | 1.1M | 2.1M | 1.4M | 2 | |
| 201801/01/2018 – 31/12/2018 | 3M | 1.1M | 2.2M | 1.4M | 2 | |
| 201701/01/2017 – 31/12/2017 | 3.2M | 1.1M | 2.3M | 1.3M | 2 | |
| 201601/01/2016 – 31/12/2016 | 2.8M | 859K | 1.8M | 983K | 2 | |
| 201501/01/2015 – 31/12/2015 | 3.1M | 577K | 1.1M | 774K | - | |
| 201401/01/2014 – 31/12/2014 | 2M | 536K | 1.2M | 947K | - | |
| 201301/01/2013 – 31/12/2013 | 596K | 291K | 584K | 411K | - | |
| 201201/01/2012 – 31/12/2012 | 557K | -174K | 227K | 120K | - |
Compared to 652 companies in Speciallægers aktiviteter
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS is 33777604.
NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS is owned by SAMBO HOLDING ApS.
The management of NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS consists of Martin Tøttrup Kelkelund.
In 2025, NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS reported a gross profit of DKK 2,685,509.
NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS had 3 employees in 2026 according to the Danish CVR register.
NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS was founded on 21 June 2011.
Claim this page to add your logo and social links. Free to get started.
NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS has published its annual report for 2025. Gross profit came to DKK 2,685,509, and the net result was DKK 964,553.
NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS has published its annual report for 2024. Gross profit came to DKK 2,489,627, and the net result was DKK 794,444.
NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS has published its annual report for 2023. Gross profit came to DKK 3,079,789, and the net result was DKK 1,191,585.
NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS has published its annual report for 2022. Gross profit came to DKK 2,100,905, and the net result was DKK 748,323.
NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS has published its annual report for 2021. Gross profit came to DKK 2,663,396, and the net result was DKK 1,167,821.
NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS has published its annual report for 2020. Gross profit came to DKK 2,571,284, and the net result was DKK 1,161,719.
NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS has published its annual report for 2019. Gross profit came to DKK 2,019,576, and the net result was DKK 1,052,331.
On August 30, 2019, the company changed its name from NEUROLOGISK SPECIALLÆGEKLINIK AALBORG ApS to NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS.
NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS has published its annual report for 2018. Gross profit came to DKK 2,986,593, and the net result was DKK 1,118,678.
NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS has published its annual report for 2017. Gross profit came to DKK 3,168,232, and the net result was DKK 1,145,601.
NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS has published its annual report for 2016. Gross profit came to DKK 2,790,172, and the net result was DKK 859,445.
NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS has published its annual report for 2015. Gross profit came to DKK 3,096,187, and the net result was DKK 576,525.
NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS has published its annual report for 2014. Gross profit came to DKK 2,009,493, and the net result was DKK 536,022.
As of March 11, 2015, REDMARK, GODKENDT REVISIONSPARTNERSELSKAB has been appointed auditor of NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS.
As of March 11, 2015, ANKJÆR-JENSEN, STATSAUTORISEREDE REVISORER A/S has stepped down as auditor of NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS.
On July 8, 2014, the company changed its name from NEUROLOGISK KLINIK SØNDERBORG ApS to NEUROLOGISK SPECIALLÆGEKLINIK AALBORG ApS.
NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS has published its annual report for 2013. Gross profit came to DKK 595,796, and the net result was DKK 291,183.
NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS has published its annual report for 2012. Gross profit came to DKK 557,054, and the net result was DKK -173,636.
As of June 30, 2012, SAMBO HOLDING ApS is registered as an owner of NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS with an ownership share of 100%.
As of July 4, 2011, ANKJÆR-JENSEN, STATSAUTORISEREDE REVISORER A/S has been appointed auditor of NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS.
As of July 4, 2011, Martin Tøttrup Kelkelund is registered as adm. dir. of NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS.
NEUROLOGISK SPECIALLÆGE MARTIN TØTTRUP KELKELUND ApS was founded on June 21, 2011.
Companies in the same industry and area
CVR 44480115
CVR 76907013
CVR 28441673
CVR 37825727
CVR 19895289
